EndoPredict® Extended Endocrine Trial (EXET)


Study Number
887720
Phase
N/A
Age Group
Adult
Purpose

The purpose of this study is to evaluate the impact of using EndoPredict® clinically to inform treatment decisions for extended endocrine therapy, and the subsequent impact on patient outcomes.

Full Title

EndoPredict® Extended Endocrine Trial (EXET): A prospective registry to evaluate the impact of the EndoPredict® test on extended endocrine treatment decisions and patient outcomes

ClinicalTrials.Gov ID
NCT04016935

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.